Three trials presented at ASCO GI 2025 will change practice and improve the treatment of colorectal cancer, according to experts.

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for ...

Dr. Marwan G. Fakih discussed the FDA approval of Lumakras with Vectibix for third-line treatment of KRAS G12C-mutated ...

Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known as ‘financial toxicity’. This strain extends beyond treatment costs to ...

Marwan G. Fakih, MD, discussed the implications of the findings from the phase 2 study for patients with microsatellite ...

GEM Hospital's 'GEM Oncoshield' initiative offers free second opinions and advanced treatments for cancer patients nationwide in February.

Jeff Dyck, a 52-year-old wealth-management professional from Calgary, said it hit particularly close to home because three ...

With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

OSANG Healthcare partners with KAIST, NANO to develop PCR tests for STIs Innovative partnership aims to enhance diagnostic ...